114 related articles for article (PubMed ID: 9336135)
1. Cost-utility analysis of a malignant glioma protocol.
Konski A; Bracy P; Weiss S; Grigsby P
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):575-8. PubMed ID: 9336135
[TBL] [Abstract][Full Text] [Related]
2. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
Murray KJ; Nelson DF; Scott C; Fischbach AJ; Porter A; Farnan N; Curran WJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):453-9. PubMed ID: 7852106
[TBL] [Abstract][Full Text] [Related]
3. Can costs be measured and predicted by modeling within a cooperative clinical trials group? Economic methodologic pilot studies of the radiation therapy oncology group (RTOG) studies 90-03 and 91-04.
Owen JB; Grigsby PW; Caldwell TM; Konski AA; Johnson DJ; Demas WF; Movsas B; Jones CU; Wasserman TH
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):633-9. PubMed ID: 11172943
[TBL] [Abstract][Full Text] [Related]
4. The costs of managing patients with malignant glioma at a neuro-oncology clinic.
Latif AZ; Signorini D; Gregor A; Whittle IR
Br J Neurosurg; 1998 Apr; 12(2):118-22. PubMed ID: 11013662
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
[TBL] [Abstract][Full Text] [Related]
7. Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme.
Kovic B; Xie F
J Clin Oncol; 2015 Jul; 33(20):2296-302. PubMed ID: 26014296
[TBL] [Abstract][Full Text] [Related]
8. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
9. A pilot cost-effectiveness analysis of treatments in newly diagnosed high-grade gliomas: the example of 5-aminolevulinic Acid compared with white-light surgery.
Esteves S; Alves M; Castel-Branco M; Stummer W
Neurosurgery; 2015 May; 76(5):552-62; discussion 562. PubMed ID: 25714513
[TBL] [Abstract][Full Text] [Related]
10. Short course radiotherapy is an appropriate option for most malignant glioma patients.
Kleinberg L; Slick T; Enger C; Grossman S; Brem H; Wharam MD
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):31-6. PubMed ID: 9212001
[TBL] [Abstract][Full Text] [Related]
11. [Modified cost-benefit analysis takes equity into consideration. Treatment of brain tumors is more cost-effective than hip replacement].
Lindholm L; Henriksson R; Rosén M; Bergenheim T; Salander P
Lakartidningen; 1999 Jun; 96(22):2749-54. PubMed ID: 10388304
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02.
Curran WJ; Scott CB; Nelson JS; Weinstein AS; Phillips TL; Murray K; Fischbach AJ; Yakar D; Schwade JG; Powlis WD
Cancer; 1992 Dec; 70(12):2909-17. PubMed ID: 1451073
[TBL] [Abstract][Full Text] [Related]
14. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years.
Hatten AL; Gatchel RJ; Polatin PB; Stowell AW
Clin J Pain; 2006 Oct; 22(8):700-11. PubMed ID: 16988566
[TBL] [Abstract][Full Text] [Related]
15. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.
Nelson DF; Diener-West M; Horton J; Chang CH; Schoenfeld D; Nelson JS
NCI Monogr; 1988; (6):279-84. PubMed ID: 3281031
[TBL] [Abstract][Full Text] [Related]
16. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
[TBL] [Abstract][Full Text] [Related]
18. Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
Lin J; Chang JS; Smiddy WE
Ophthalmology; 2016 Sep; 123(9):1912-8. PubMed ID: 27425822
[TBL] [Abstract][Full Text] [Related]
19. Cost-Utility of Evaluation for Posterior Vitreous Detachment and Prophylaxis of Retinal Detachment.
Yannuzzi NA; Chang JS; Brown GC; Smiddy WE
Ophthalmology; 2018 Jan; 125(1):43-50. PubMed ID: 28732590
[TBL] [Abstract][Full Text] [Related]
20. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
